Omeprazolo Doc Generici (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Doc Generici, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omeprazolo Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief and healing in several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in chronic NSAID users.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Acute interstitial nephritis: may present with renal impairment. - Severe hypersensitivity reactions: including rash, angioedema, or anaphylaxis. - Clostridioides difficile‑associated colitis: risk increases with prolonged use. - Osteoporotic fractures: especially with long‑term therapy. - Vitamin B12 deficiency: may develop after extended treatment. - Thrombotic thrombocytopenic purpura (very rare).

Before initiating therapy, consider patient‑specific factors and monitor for potential complications.

- Assess renal and hepatic function: dose adjustment may be required in severe impairment. - Review concomitant medications: omeprazole can affect the absorption of drugs that need an acidic environment. - Use the lowest effective dose: limit duration to the shortest period necessary for symptom control. - Counsel patients on fracture risk: advise calcium and vitamin D intake for long‑term users. - Monitor for signs of infection: especially gastrointestinal infections with prolonged use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can modify the pharmacokinetics of several drugs; careful review is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir and other protease inhibitors: decreased absorption, loss of antiviral efficacy. - Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Methotrexate: increased serum levels, especially with high‑dose regimens. - Digoxin: higher plasma concentrations may occur. - Diazepam: enhanced sedation due to slower metabolism. - Iron supplements: reduced absorption, advise spacing doses. - Ketoconazole and other azole antifungals: decreased bioavailability.